DNA-PK
The DNA-PK holoenzyme comprises a heterodimer of approximately 70- and 80-kDa polypeptides, known as Ku, that binds to DNA strand breaks, recruiting and activating the 470-kDa catalytic subunit, termed DNA-PKcs. Cells lacking DNA-PK are hypersensitive to IR and cross-linking agents and defective in DSB repair. DNA-PK, together with the x-ray cross complementing (XRCC4)/DNA ligase IV complex and the recently identified cofactor Artemis, is specifically required for NHEJ, with about 80% of DNA DSBs repaired by this pathway. DNA-PK can accelerate the repair of IR-, etoposide-, and doxorubicin-induced DSBs, thus conferring resistance to these agents. The inhibition of DNA-PK is an attractive approach for modulating resistance to therapeutically-induced DNA DSBs.
References
1.Furgason JM,et al. Pharmacol Ther. 2013;137(3):298–308.
References
1.Furgason JM,et al. Pharmacol Ther. 2013;137(3):298–308.
Cell Cycle/DNA Damage
ABC(12)
AChR(42)
Antifolate(10)
ATM/ATR(24)
Aurora Kinase(46)
CLK(15)
c-Myc(22)
DHFR(7)
DNA Alkylator(33)
DNA gyrase(10)
DNA Repair Protein(21)
DNA/RNA Synthesis(141)
DNA-PK(13)
GPR(66)
HDAC(138)
Hec1/Nek2(9)
Integrin(55)
LIM Kinase (LIMK)(7)
Mps1/TTK(2)
Nucleoside Antimetabolite/Analog(48)
Other Targets(4)
PARP(50)
PLK(19)
Potassium Channel(107)
RAD51(1)
Rho(10)
ROCK(29)
Telomerase(9)
Topoisomerase(61)
Wee1(4)